Unum earnings beat by $0.03, revenue fell short of estimates

Unum (UNM) reported Q3 EPS of $2.20, beating estimates by $0.03, but revenue of $2.55B fell short of the $2.91B consensus. The stock is up 0.52% in 3 months and 16.41% in 12 months. InvestingPro rates its financial health as 'good performance'.

Original reporting
Published Nov 3, 2026, 9:38 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 3, 2026, 9:49 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$UNM
Neutral
high confidence
Mentioned
$UNM
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$UNMNeutralMed
01

Why it matters

The earnings beat on EPS may attract short-term buying, but the revenue shortfall could prompt profit-taking.

02

Market read

The report provides fresh earnings data that could influence trading decisions in the insurance sector.

03

What to watch

Potential cost-cutting measures or upcoming product launches not disclosed may mitigate revenue concerns.

Relevance 7/10Novelty 7/10Timing: post-market today

Background

Unum's Q3 results were released on November 3, 2026, with mixed performance metrics.

Company-level read

Ticker impact

$UNMNeutralHigh confidence
Context

Unum reported Q3 EPS of $2.20, beating estimates by $0.03, while revenue missed at $2.55B versus $2.91B consensus.

Expected impact

likely slight pressure as investors weigh revenue shortfall against EPS beat

Evidence & confidence

EPS beat is modest and revenue miss is sizable; traders may hold or trim positions pending guidance.

Market effects

Insurance sector may see mixed sentiment as earnings highlight pricing pressure.

U.S. insurers could experience slight volatility in after-hours trading.

Limited; primarily affects U.S. market participants.

Counterpoint

Despite revenue miss, the EPS beat could signal operational efficiency and support a short-term rally.

Key entities

  • Unum

    U.S. insurance provider (NYSE: UNM).

Related articles

$UNMMed

Unum Group Stocks Climb 5.19% After JPMorgan Upgrade to Overweight

Unum Group (NYSE:UNM) shares rose 5.19% to $80.74 after JPMorgan upgraded it to Overweight, lowering its price target to $90. The firm cited attractive risk/reward despite lower estimates. Unum reported a Q3 net loss of $2.65 per share due to a $853 million investment loss, but adjusted operating income was $2.20 per share. Core premiums grew 4.7%, while US sales fell 8.5%. The company expects full-year adjusted operating income of $8.30 to $8.50 per share.

$UNMHigh

Unum Group Q3 Earnings Call Highlights

Unum Group (UNM) reported Q3 earnings, noting long-term disability claims 10% above expectations, driven by behavioral health. The company is implementing double-digit rate increases and expects full-year 2026 earnings of $8.30-$8.50 per share. Unum also completed a reinsurance transaction, reducing long-term care exposure by over 40%.

$UNMMedAI 8/10

Unum Group (UNM) (Q3 2026) Earnings Call Highlights: Disability Claims Surge Weighs

Unum Group (UNM) reported Q3 2026 earnings with mixed results. Core premiums grew 5%, and the company returned $1B to shareholders. However, earnings per share of $2.20 missed expectations due to higher disability claims. The group disability benefit ratio rose to 70.6%, and the full-year EPS outlook was revised to $8.30-$8.50. Management attributed the increase in claims to behavioral health issues and expects pricing actions to address the trend.

$UNMHighAI 9/10

Why is Unum stock crashing today?

Unum Group (UNM) stock fell 18.7% to $74.03 after reporting a Q3 2026 GAAP net loss of $419.7M, revenue shortfall of $360M, and adjusted EPS decline of 21%. Barclays cut its price target to $101. The drop is attributed to reinsurance-related charges, rising disability claims, and market focus on earnings deterioration.